Loading...
Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
Cyclophosphamide plus G-CSF (C+G-CSF) is one of the most widely used stem cell (SC) mobilization regimens for patients with multiple myeloma (MM). Plerixafor plus G-CSF (P+G-CSF) has demonstrated superior SC mobilization efficacy when compared with G-CSF alone and has been shown to rescue patients w...
Na minha lista:
| Udgivet i: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337097/ https://ncbi.nlm.nih.gov/pubmed/26726942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.322 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|